Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Dendreon Corporation    DNDN   US24823Q1076

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/16/2014 04/17/2014 04/21/2014 04/22/2014 04/23/2014 Date
2.69(c) 2.65(c) 2.66(c) 2.68(c) 2.695 Last
2 244 867 2 183 472 1 576 677 2 616 170 24 200 Volume
0.00% -1.49% +0.38% +0.75% +0.56% Change
More quotes
Company
Dendreon Corp. is a biotechnology company, which focuses on discovery, development and commercialization of novel therapeutics that improves cancer treatment options for patients. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular... 
Sector
Biotechnology
Calendar
05/05Earnings Release
Surperformance© rating of Dendreon Corporation
Trading Rating : Investor Rating :
More about the company
Chart DENDREON CORPORATION
Duration : Period :
Dendreon Corporation Technical Analysis Chart | DNDN | US24823Q1076 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 302 M
EBIT 2014 -93,1 M
Net income 2014 -142 M
Debt 2014 352 M
Yield 2014 -
Sales 2015 351 M
EBIT 2015 -32,1 M
Net income 2015 -88,5 M
Debt 2015 455 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 2,57x
EV / Sales 2015 2,50x
Capitalization 423 M
More Financials
Latest news on DENDREON CORPORATION
6d ago DENDREON : Releases Preliminary Data from Analysis of Phase II Stand Study
04/11 DENDREON : Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T)..
03/12 DENDREON : Announces Fourth Quarter and 2013 Year End Results
03/12 DENDREON : Announces Plans to Make PROVENGE® Commercially Available in Europe
03/10 Exclusive - Germany OKs Northwest Bio brain cancer drug, shares soar
03/07 DENDREON CORPORATION : DENDREON CORP FILES (8-K) Disclosing Change in Directors ..
03/06 DENDREON CORPORATION : Dendreon Reports Intent to Make Provenge Commercially Ava..
03/05 DENDREON CORPORATION : Patent Issued for Promiscuous HER-2/Neu CD4 T Cell Epitop..
03/04 DENDREON CORPORATION : Dendreon Corp. Assigned Patent
03/03 DENDREON CORPORATION : Dendreon Tests Resistance on Earnings Report, Provenge Ex..
03/03DJU.S. HOT STOCKS : Hot Stocks to Watch
03/03 Dendreon shares jump on news of prostate drug's European launch
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
Dendreon Corporation : Income Statement Evolution
More Financials
EPS Revisions
Dendreon Corporation : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF